E280 - PsychopharmaPearls: Managing Rebound Insomnia with Dr. Thomas Schwartz

In this episode, Dr. Andy Cutler speaks with Dr. Thomas Schwartz about insomnia related to antidepressant discontinuation, including how rebound and withdrawal symptoms can emerge when tapering or stopping treatment. They review the underlying mechanisms, clinical risk factors, and how to distinguish discontinuation-related insomnia from relapse of depression or primary sleep disorders. The discussion emphasizes practical, evidence-informed strategies for safely tapering antidepressants and managing sleep disturbance in psychiatric practice. Thomas L. Schwartz , MD, is a Distinguished Teaching Professor at Norton College of Medicine, SUNY Upstate Medical University in Syracuse, New York. He is an award-winning educator deeply involved in medical student and resident training, as well as the development of continuing medical education in psychiatry. Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and EMA Wellness. He is a Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York . Save $100 on registration for 2026 NEI Spring Congress with code NEIPOD26 Register today at nei.global /spring Never miss an episode! 🎙

You can listen to E280 - PsychopharmaPearls: Managing Rebound Insomnia with Dr. Thomas Schwartz online on Radio and Podcast. Open the player on this page to stream the available audio.

E280 - PsychopharmaPearls: Managing Rebound Insomnia with Dr. Thomas Schwartz is an episode from NEI Podcast by Neuroscience Education Institute.

This episode is 33:45 long.

This episode was published on Apr 22, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from NEI Podcast when more episodes are available from the podcast feed.